McCune-Albright syndrome

Orphanet Journal of Rare Diseases

Volumn 3, Issue 1, 2008, Pages

  Dumitrescu, Claudia E ^a   Collins, Michael T ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALBRIGHT SYNDROME; ARTICLE; CAFE AU LAIT SPOT; CHILD; ENDOCRINE DISEASE; FEMALE; GENETIC COUNSELING; GENETICS; GIGANTISM; HUMAN; HYPERTHYROIDISM; MALE; PATHOPHYSIOLOGY; PRECOCIOUS PUBERTY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CAFE-AU-LAIT SPOTS; CHILD; CHILD, PRESCHOOL; ENDOCRINE SYSTEM DISEASES; FEMALE; FIBROUS DYSPLASIA, POLYOSTOTIC; GENETIC COUNSELING; GIGANTISM; HUMANS; HYPERTHYROIDISM; MALE; PUBERTY, PRECOCIOUS;

EID: 47349094443     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-3-12     Document Type: Review

References (71)

1. Osteitis fibrosa cystica: the case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. DJ McCune, Am J Dis Child 1936 52 743 744
2. Syndrome characterized by osteitis fibrosa disseminata, areas, of pigmentation, and endocrine dysfunction, with precocious puberty in females: report of 5 cases. F Albright AM Butler AO Hampton P Smith, N Engl J Med 1937 216 727 746
3. Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. G Mastorakos NS Mitsiades AG Doufas DA Koutras, Thyroid 1997 7 433 439 9226216
4. Octreotide therapy of growth hormone excess in the McCune-Albright syndrome. SI Sherman PW Ladenson, Journal of endocrinological investigation 1992 15 185 190 1624678
5. Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. SO Akintoye C Chebli S Booher P Feuillan H Kushner D Leroith N Cherman P Bianco S Wientroub PG Robey MT Collins, J Clin Endocrinol Metab 2002 87 11 5104 5112 10.1210/jc.2001-012022 12414879
6. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. MT Collins C Chebli J Jones H Kushner M Consugar P Rinaldo S Wientroub P Bianco PG Robey, J Bone Miner Res 2001 16 806 813 10.1359/jbmr.2001.16.5.806 11341325
7. The McCune-Albright syndrome. M Danon JD Crawford, Ergeb Inn Med Kinderheilkd 1987 55 81 115 3545811
8. McCune-Albright syndrome and disorders due to activating mutations of GNAS1. A Diaz M Danon J Crawford, J Pediatr Endocrinol Metab 2007 20 853 880 17937059
9. Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. JM Kirk CE Brain DJ Carson JC Hyde DB Grant, The Journal of pediatrics 1999 134 789 792 10.1016/S0022-3476(99)70302-1 10356155
10. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. A Shenker LS Weinstein A Moran OH Pescovitz NJ Charest CM Boney JJ Van Wyk MJ Merino PP Feuillan AM Spiegel, J Pediatr 1993 123 509 518 10.1016/S0022-3476(05) 80943-6 8410501
11. Fibrous dysplasia of bone: a condition affecting one, several or many bones, graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. LJH Lichtenstein, Arch Path 1942 33 777 816
12. Fibrous dysplasia. P Bianco PG Robey S Wientroub, Pediatric Bone: Biology and Disease New York, NY: Academic Press, Elsevier, Glorieux FH, Pettifor J, Juppner H, 2003 509 539
13. Spectrum and natural history of fibrous dysplasia of bone. MT Collins, J Bone Miner Res 2006 21 Suppl 2 P99 P104 10.1359/jbmr.06s219 17229019
14. Fibrous dysplasia. MT Collins P Bianco, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism Washington, D.C.: American Society for Bone and Mineral Research, Favus MJ, 6 2006 415 418
15. McCune-Albright syndrome: new insights. MT Collins A Shenker, Curr Opin in Endocrinol and Diabetes 1999 6 119 125 10.1097/00060793-199904000-00006
16. Fibroosseous Lesions. HD Dorfman B Czerniak, Bone Tumors St. Louis, MO: Mosby, Dorfman HD, Czerniak B, 1998 441 491
17. Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. ES Hart MH Kelly B Brillante CC Chen N Ziran JS Lee P Feuillan AI Leet H Kushner PG Robey MT Collins, J Bone Miner Res 2007 22 1468 1474 10.1359/jbmr.070511 17501668
18. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome. AI Leet C Chebli H Kushner CC Chen MH Kelly BA Brillante PG Robey P Bianco S Wientroub MT Collins, J Bone Miner Res 2004 19 571 577 10.1359/JBMR.0301262 15005844
19. Malignancies in fibrous dysplasia. P Ruggieri FH Sim JR Bond KK Unni, Cancer 1994 73 1411 1424 10.1002/1097-0142(19940301)73:5<1411::AID- CNCR2820730516>3.0.CO;2-T 8111708
20. Chondrosarcoma in a patient with McCune-Albright syndrome. Report of a case. P Blanco T Schaeverbeke L Baillet L Lequen B Bannwarth J Dehais, Rev Rhum Engl Ed 1999 66 177 179 10327499
21. Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome. R Lopez-Ben MJ Pitt KA Jaffe GP Siegal, Skeletal Radiol 1999 28 522 526 10.1007/s002560050556 10525796
22. Breast carcinoma in a 11-year-old girl with Albright's syndrome. EF Scanlon FE Burkett SF Sener OC Green HS Traisman TJ Marr TA Victor ML Crist, Breast 1980 6
23. Breast Cancer in a Patient with McCune-Albright Syndrome. Y Tanabeu S Nakahara S Mitsuyama M Ono S Toyoshima, Breast Cancer 1998 5 175 178 11091644
24. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. MT Collins NJ Sarlis MJ Merino J Monroe SE Crawford JA Krakoff LC Guthrie S Bonat PG Robey A Shenker, J Clin Endocrinol Metab 2003 88 4413 4417 10.1210/jc.2002-021642 12970318
25. Activating mutations of the stimulatory G protein in the McCune - Albright syndrome [see comments]. LS Weinstein A Shenker PV Gejman MJ Merino E Friedman AM Spiegel, N Engl J Med 1991 325 1688 1695 1944469
26. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. WF Schwindinger CA Francomano MA Levine, Proc Natl Acad Sci USA 1992 89 5152 5156 1594625 10.1073/pnas.89.11.5152
27. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. P Bianco M Riminucci A Majolagbe SA Kuznetsov MT Collins MH Mankani A Corsi HG Bone S Wientroub AM Spiegel LW Fisher PG Robey, J Bone Miner Res 2000 15 120 128 10.1359/jbmr.2000.15.1.120 10646121
28. A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone. BD Idowu M Al-Adnani P O'Donnell L Yu E Odell T Diss RE Gale AM Flanagan, Histopathology 2007 50 691 704 10.1111/j.1365-2559.2007.02676.x 17493233
29. Fibrous dysplasia as a stem cell disease. M Riminucci I Saggio PG Robey P Bianco, J Bone Miner Res 2006 21 Suppl 2 P125 131 10.1359/jbmr.06s224 17229001
30. An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone. MT Collins H Kushner JC Reynolds C Chebli MH Kelly A Gupta B Brillante AI Leet M Riminucci PG Robey P Bianco S Wientroub CC Chen, J Bone Miner Res 2005 20 219 226 10.1359/JBMR.041111 15647815
31. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. E Ippolito EW Bray A Corsi F De Maio UG Exner PG Robey F Grill R Lala M Massobrio O Pinggera M Riminucci S Snela C Zambakidis P Bianco, Journal of pediatric orthopaedics 2003 12 155 177 10.1097/00009957-200305000-00001 12703030
32. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. MH Kelly B Brillante MT Collins, Osteoporos Int 2007 17622477
33. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. M Riminucci B Liu A Corsi A Shenker AM Spiegel PG Robey P Bianco, The Journal of pathology 1999 187 249 258 10.1002/(SICI)1096- 9896(199901)187:2<249::AID-PATH222>3.0.CO;2-J 10365102
34. Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations. A Corsi MT Collins M Riminucci PG Howell A Boyde PG Robey P Bianco, J Bone Miner Res 2003 18 1235 1246 10.1359/jbmr.2003.18.7.1235 12854833
35. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone? TS Hannon K Noonan R Steinmetz EA Eugster MA Levine OH Pescovitz, J Pediatr 2003 142 532 538 10.1067/mpd.2003.153 12756386
36. Center for Genetic Testing. http://www.sfh-lab.com
37. Genome Diagnostics. http://www.umcutrecht.nl/subsite/genome-diagnostics/ DNA-diagnostics/Gene-Tests.htm
38. Forensic considerations in cases of neurofibromatosis - an overview. RW Byard, Journal of forensic sciences 2007 52 1164 1170 10.1111/j.1556-4029.2007. 00512.x 17645486
39. Pathophysiology of neurofibromatosis type 1. A Theos BR Korf, Annals of internal medicine 2006 144 842 849 16754926
40. Normal vision despite narrowing of the optic canal in fibrous dysplasia. JS Lee E FitzGibbon JA Butman CR Dufresne H Kushner S Wientroub PG Robey MT Collins, N Engl J Med 2002 347 1670 1676 10.1056/NEJMoa020742 12444181
41. Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation. CM Cutler JS Lee JA Butman EJ FitzGibbon MH Kelly BA Brillante P Feuillan PG Robey CR DuFresne MT Collins, Neurosurgery 2006 59 1011 1017 discussion 1017-1018 17143235
42. Thyroid abnormalities in the McCune-Albright syndrome: ultrasonography and hormone studies. PP Feuillan T Shawker SR Rose J Jones RK Jeevanram BC Nisula, J Clin Endocrinol Metab 1990 71 1596 1601 2229316
43. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. M Riminucci MT Collins NS Fedarko N Cherman A Corsi KE White S Waguespack A Gupta T Hannon MJ Econs P Bianco P Gehron Robey, J Clin Invest 2003 112 683 692 12952917
44. Bone mineralization in polyostotic fibrous dysplasia: histomorphometric analysis. L Terpstra F Rauch H Plotkin R Travers FH Glorieux, J Bone Miner Res 2002 17 1949 1953 10.1359/jbmr.2002.17.11.1949 12412801
45. Medical therapy of children with fibrous dysplasia. FH Glorieux F Rauch, J Bone Miner Res 2006 21 Suppl 2 P110 113 10.1359/jbmr.06s221 17228998
46. Primary hyperparathyroidism-associated polyostotic fibrous dysplasia: absence of McCune-Albright syndrome mutations. MM Hammami SS Hussain LJ Vencer A Butt A al-Zahrani, J Endocrinol Invest 1997 20 552 558 9413810
47. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. A Barone A Giusti G Pioli G Girasole M Razzano M Pizzonia E Palummeri G Bianchi, Journal of the American Geriatrics Society 2007 55 752 757 10.1111/j.1532-5415.2007.01161.x 17493196
48. High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. A Giusti A Barone M Razzano M Pizzonia M Oliveri E Palummeri G Pioli, Journal of endocrinological investigation 2006 29 809 813 17114912
49. The high prevalence of inadequate serum vitamin D levels and implications for bone health. JY Reginster, Current medical research and opinion 2005 21 579 586 10.1185/030079905X41435
50. The status of biochemical parameters in varying degrees of vitamin D deficiency. S Hashemipour B Larijani H Adibi M Sedaghat M Pajouhi MH Bastan-Hagh A Soltani E Javadi AR Shafaei R Baradar-Jalili A Hossein-Nezhad, Journal of bone and mineral metabolism 2006 24 213 218 10.1007/s00774-005-0674-8
51. Surgery for fibrous dysplasia. RP Stanton, J Bone Miner Res 2006 21 Suppl 2 P105 109 10.1359/jbmr.06s220 17228997
52. Medical therapy in adults with fibrous dysplasia of bone. RD Chapurlat, J Bone Miner Res 2006 21 Suppl 2 P114 119 10.1359/jbmr.06s222 17228999
53. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. D Liens PD Delmas PJ Meunier, Lancet 1994 343 953 954 10.1016/S0140- 6736(94)90069-8 7909013
54. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. H Plotkin F Rauch L Zeitlin C Munns R Travers FH Glorieux, J Clin Endocrinol Metab 2003 88 4569 4575 10.1210/jc.2003-030050 14557424
55. Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood. B Chan M Zacharin, J Pediatr Endocrinol Metab 2006 19 75 80 16509531
56. Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis. AI Leet E Magur JS Lee S Wientroub PG Robey MT Collins, J Bone Joint Surg Am 2004 86-A 3 531 537 14996879
57. Letrozole Treatment of Precocious Puberty in Girls with the McCune-Albright Syndrome: A Pilot Study. P Feuillan K Calis S Hill T Shawker PG Robey MT Collins, J Clin Endocrinol Metab 2007 92 2100 2106 10.1210/jc.2006-2350 17405850
58. Treatment of sexual precocity in girls with the McCune-Albright syndrome. PP Feuillan, Sexual precocity: etiology, diagnosis and management New York: Raven Press, Grave GD, Cutler GB, 1993 243 251
59. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. EA Eugster SD Rubin EO Reiter P Plourde HC Jou OH Pescovitz, The Journal of pediatrics 2003 143 60 66 10.1016/S0022-3476(03)00128-8 12915825
60. Thyroid disease in patients with McCune-Albright syndrome. V Congedo FS Celi, Pediatr Endocrinol Rev 2007 4 Suppl 4 429 433 17982391
61. Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome. SO Akintoye MH Kelly B Brillante N Cherman S Turner JA Butman PG Robey MT Collins, J Clin Endocrinol Metab 2006 91 2960 2966 10.1210/jc.2005-2661 16720661
62. McCune-Albright syndrome in adulthood. P Chanson S Salenave P Orcel, Pediatr Endocrinol Rev 2007 4 Suppl 4 453 462 17982395
63. McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients. F Galland P Kamenicky H Affres Y Reznik D Pontvert Y Le Bouc J Young P Chanson, J Clin Endocrinol Metab 2006 91 4957 4961 10.1210/jc.2006-0561 16984995
64. Fibrous dysplasia of bone and primary hyperparathyroidism. U Ehrig DR Wilson, Ann Intern Med 1972 77 234 238 4641656
65. Panostotic fibrous dysplasia. A new craniotubular dysplasia. WD Leslie C Reinhold L Rosenthall C Tau FH Glorieux, Clinical nuclear medicine 1992 17 556 560 10.1097/00003072-199207000-00005 1638836
66. McCune-Albright syndrome. PP Feuillan, Curr Ther Endocrinol Metab 1997 6 235 239 9174745
67. Image diagnosis in McCune-Albright syndrome. C Defilippi D Chiappetta D Marzari A Mussa R Lala, J Pediatr Endocrinol Metab 2006 19 Suppl 2 561 570 16789618
68. Demonstration of McCune-Albright mutations in the liver of children with high gammaGT progressive cholestasis. ES Silva S Lumbroso M Medina Y Gillerot C Sultan EM Sokal, Journal of hepatology 2000 32 154 158 10.1016/S0168-8278(00) 80202-0 10673080
69. Fetal and neonatal hyperthyroidism. D Zimmerman, Thyroid 1999 9 727 733 10447021
70. Cutaneous fibrous dysplasia: an incomplete form of the McCune-Albright syndrome. RA Schwartz MS Spicer CB Leevy JB Ticker WC Lambert, Dermatology (Basel, Switzerland) 1996 192 258 261 8726643
71. [Cutaneous manifestations of McCune-Albright syndrome: report of a case (author's transl)]. AM Pierini JP Ortonne D Floret, Annales de dermatologie et de venereologie 1981 108 969 976 7337370